A detailed history of Deutsche Bank Ag\ transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 460,530 shares of BCRX stock, worth $3.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
460,530
Previous 431,994 6.61%
Holding current value
$3.36 Million
Previous $2.67 Million 31.14%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.41 - $8.69 $182,915 - $247,977
28,536 Added 6.61%
460,530 $3.5 Million
Q2 2024

Aug 14, 2024

SELL
$4.13 - $6.79 $1.31 Million - $2.15 Million
-316,800 Reduced 42.31%
431,994 $2.67 Million
Q1 2024

May 15, 2024

SELL
$4.89 - $7.65 $1.36 Million - $2.12 Million
-277,248 Reduced 27.02%
748,794 $3.8 Million
Q4 2023

Feb 14, 2024

BUY
$4.98 - $6.77 $4.61 Million - $6.27 Million
926,331 Added 929.02%
1,026,042 $6.15 Million
Q3 2023

Nov 09, 2023

BUY
$6.71 - $7.92 $70,448 - $83,152
10,499 Added 11.77%
99,711 $705,000
Q2 2023

Aug 14, 2023

SELL
$6.96 - $8.81 $360,138 - $455,864
-51,744 Reduced 36.71%
89,212 $628,000
Q1 2023

May 15, 2023

BUY
$7.94 - $11.84 $253,571 - $378,122
31,936 Added 29.29%
140,956 $1.18 Million
Q4 2022

Feb 13, 2023

BUY
$10.5 - $14.2 $239,242 - $323,547
22,785 Added 26.42%
109,020 $1.25 Million
Q3 2022

Nov 14, 2022

SELL
$10.79 - $14.81 $183,030 - $251,222
-16,963 Reduced 16.44%
86,235 $1.09 Million
Q2 2022

Aug 11, 2022

SELL
$7.89 - $17.88 $63,822 - $144,631
-8,089 Reduced 7.27%
103,198 $1.09 Million
Q1 2022

May 13, 2022

SELL
$11.56 - $19.76 $119,391 - $204,081
-10,328 Reduced 8.49%
111,287 $1.81 Million
Q4 2021

Feb 11, 2022

SELL
$11.18 - $15.46 $1.01 Million - $1.4 Million
-90,584 Reduced 42.69%
121,615 $1.69 Million
Q3 2021

Nov 04, 2021

BUY
$14.21 - $17.65 $999,048 - $1.24 Million
70,306 Added 49.55%
212,199 $3.05 Million
Q2 2021

Aug 11, 2021

BUY
$9.5 - $17.24 $119,434 - $216,741
12,572 Added 9.72%
141,893 $2.24 Million
Q1 2021

May 13, 2021

SELL
$7.37 - $13.61 $101,389 - $187,232
-13,757 Reduced 9.62%
129,321 $1.32 Million
Q4 2020

Feb 16, 2021

BUY
$3.37 - $8.61 $109,804 - $280,539
32,583 Added 29.49%
143,078 $1.07 Million
Q3 2020

Nov 12, 2020

BUY
$3.43 - $5.53 $5,515 - $8,892
1,608 Added 1.48%
110,495 $380,000
Q2 2020

Aug 13, 2020

SELL
$1.9 - $5.61 $4.2 Million - $12.4 Million
-2,211,572 Reduced 95.31%
108,887 $518,000
Q1 2020

May 14, 2020

SELL
$1.6 - $4.11 $2.37 Million - $6.09 Million
-1,482,795 Reduced 38.99%
2,320,459 $4.64 Million
Q4 2019

Feb 14, 2020

BUY
$1.59 - $3.45 $5.46 Million - $11.8 Million
3,432,643 Added 926.21%
3,803,254 $13.1 Million
Q3 2019

Nov 14, 2019

BUY
$2.5 - $3.73 $333,805 - $498,037
133,522 Added 56.32%
370,611 $1.06 Million
Q2 2019

Aug 14, 2019

SELL
$2.91 - $9.15 $38,100 - $119,800
-13,093 Reduced 5.23%
237,089 $896,000
Q1 2019

May 15, 2019

BUY
$7.38 - $9.72 $1.1 Million - $1.45 Million
148,972 Added 147.19%
250,182 $2.03 Million
Q4 2018

Feb 14, 2019

SELL
$6.51 - $9.6 $3.07 Million - $4.52 Million
-471,253 Reduced 82.32%
101,210 $816,000
Q3 2018

Dec 21, 2021

BUY
$5.52 - $7.99 $737,080 - $1.07 Million
133,529 Added 30.42%
572,463 $4.37 Million
Q3 2018

Nov 14, 2018

SELL
$5.52 - $7.99 $975,008 - $1.41 Million
-176,632 Reduced 28.69%
438,934 $3.35 Million
Q2 2018

Apr 21, 2020

BUY
$4.6 - $6.52 $218,131 - $309,178
47,420 Added 8.35%
615,566 $3.53 Million
Q2 2018

Aug 14, 2018

SELL
$4.6 - $6.52 $1.62 Million - $2.3 Million
-352,588 Reduced 38.29%
568,146 $3.25 Million
Q1 2018

Oct 18, 2019

BUY
$4.35 - $5.82 $815,912 - $1.09 Million
187,566 Added 25.58%
920,734 $4.39 Million
Q1 2018

May 15, 2018

BUY
$4.35 - $5.82 $906,983 - $1.21 Million
208,502 Added 39.74%
733,168 $3.5 Million
Q4 2017

Feb 14, 2018

BUY
$4.16 - $5.33 $1.12 Million - $1.44 Million
270,147 Added 106.14%
524,666 $2.57 Million
Q3 2017

Nov 14, 2017

BUY
$4.1 - $5.97 $1.04 Million - $1.52 Million
254,519
254,519 $1.33 Million

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.36B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.